z-logo
open-access-imgOpen Access
An overview of CAR T-cell clinical trial activity to 2021
Author(s) -
Antonella Adami,
John Maher
Publication year - 2021
Publication title -
immunotherapy advances
Language(s) - English
Resource type - Journals
ISSN - 2732-4303
DOI - 10.1093/immadv/ltab004
Subject(s) - medicine
Summary Immunotherapy of cancer using chimeric antigen receptor-engineered T-cells has transformed the management of selected haematological malignancies, triggering intense clinical trial activity in this arena. This article summarises trial activity that has been published to date across the spectrum of haematological and solid tumour types.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom